Nasdaq OMX

Novavax, Inc.


Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017

GAITHERSBURG, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday, August 8, 2017.

Conference call details are as follows:

Date: Tuesday, August 8, 2017
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode: 15614203
Webcast: , "Investors"/ "Events"

Conference call and webcast replay:

Dates: Starts at 7:30 p.m. ET, August 8, 2017 until 7:30 pm ET, August 15, 2017
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)  
Passcode: 15614203  
Webcast: , "Investors"/ "Events", until November 8, 2017

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.


Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor Relations  
Westwicke Partners
John Woolford

Russo Partners, LLC
David Schull
Todd Davenport, Ph.D. 


Information om Nasdaq OMX

Nasdaq OMX
Nasdaq OMX
Nikolaj Plads 6
1007 København K

+45 3377 0377